X-56994254-C-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_001010862.3(SPIN3):c.694G>T(p.Val232Leu) variant causes a missense change. The variant allele was found at a frequency of 0.00014 in 1,209,912 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 61 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00013 ( 0 hom., 6 hem., cov: 23)
Exomes 𝑓: 0.00014 ( 0 hom. 55 hem. )
Consequence
SPIN3
NM_001010862.3 missense
NM_001010862.3 missense
Scores
1
8
8
Clinical Significance
Conservation
PhyloP100: 6.13
Genes affected
SPIN3 (HGNC:27272): (spindlin family member 3) Enables methylated histone binding activity. Predicted to be involved in regulation of transcription, DNA-templated. Predicted to be integral component of membrane. Predicted to be active in cytosol and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.3071554).
BS2
High Hemizygotes in GnomAd4 at 6 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPIN3 | NM_001010862.3 | c.694G>T | p.Val232Leu | missense_variant | 2/2 | ENST00000374919.6 | NP_001010862.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPIN3 | ENST00000374919.6 | c.694G>T | p.Val232Leu | missense_variant | 2/2 | 1 | NM_001010862.3 | ENSP00000364054.3 | ||
SPIN3 | ENST00000639257.1 | n.225+469G>T | intron_variant | 3 | ENSP00000492259.1 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 14AN: 111806Hom.: 0 Cov.: 23 AF XY: 0.000177 AC XY: 6AN XY: 33972
GnomAD3 genomes
AF:
AC:
14
AN:
111806
Hom.:
Cov.:
23
AF XY:
AC XY:
6
AN XY:
33972
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000170 AC: 31AN: 182521Hom.: 0 AF XY: 0.000207 AC XY: 14AN XY: 67567
GnomAD3 exomes
AF:
AC:
31
AN:
182521
Hom.:
AF XY:
AC XY:
14
AN XY:
67567
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000141 AC: 155AN: 1098106Hom.: 0 Cov.: 30 AF XY: 0.000151 AC XY: 55AN XY: 363460
GnomAD4 exome
AF:
AC:
155
AN:
1098106
Hom.:
Cov.:
30
AF XY:
AC XY:
55
AN XY:
363460
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000125 AC: 14AN: 111806Hom.: 0 Cov.: 23 AF XY: 0.000177 AC XY: 6AN XY: 33972
GnomAD4 genome
AF:
AC:
14
AN:
111806
Hom.:
Cov.:
23
AF XY:
AC XY:
6
AN XY:
33972
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
24
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 05, 2024 | The c.694G>T (p.V232L) alteration is located in exon 2 (coding exon 1) of the SPIN3 gene. This alteration results from a G to T substitution at nucleotide position 694, causing the valine (V) at amino acid position 232 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;T;T;T;T;.
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;.;.;.;.;.;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;M;M;M;M;.
PrimateAI
Uncertain
T
PROVEAN
Benign
N;.;.;.;.;.;.
REVEL
Uncertain
Sift
Uncertain
D;.;.;.;.;.;.
Sift4G
Uncertain
D;.;.;.;.;.;.
Polyphen
D;D;D;D;D;D;.
Vest4
MutPred
Gain of catalytic residue at V232 (P = 0.0784);Gain of catalytic residue at V232 (P = 0.0784);Gain of catalytic residue at V232 (P = 0.0784);Gain of catalytic residue at V232 (P = 0.0784);Gain of catalytic residue at V232 (P = 0.0784);Gain of catalytic residue at V232 (P = 0.0784);.;
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at